Insulet (PODD) RSU sell-vs-hold

Calculator · free · no signup · PODD

Sell at vest or hold? Compare after-tax payout from selling Insulet RSUs at vest vs. holding through the LTCG cliff at 12 months.

Beta · invite-only · AlphaLatitude Inc. · Free Tools

Your vest

pre-IPO? enter price manually

Tax inputs

Hold strategy

1 yr
20%
20%
10.0%

Best after-tax payout — at year 1 yr

$47,709

Sell + invest wins by $4,981 over Hold 1 yr.

Estimates only. Not financial advice.

This vest pushes your top federal rate from 24% to 35%. Hover the Federal value below for the bracket-by-bracket slicing.

Heads-up: under-withholding. Your employer withholds federal tax at the IRS supplemental rate (22.0% on this vest, ≈ $17,600). Your marginal federal rate on this vest is 32.7%, owing $26,171. Expect to settle the $8,571 gap at tax time.

The hidden purchase

Tax was paid at vest either way. Holding is mathematically equivalent to taking $44,509 in after-tax cash and buying $44,509 of PODD today.

Most diversification frameworks would advise against a purchase that size in a single name; the right answer depends on your conviction in PODD. Holding past one year converts the gain to LTCG.

Sell + invest

Best payout
Vest value (shares × price)$80,000
Federal
State
Medicare$1,160
Additional Medicare$720
Market gain over 1 yr at 10.0%$4,451
Cap-gain tax on diversified gain — LTCG (federal + state + NIIT)$1,251
Net at year 1 yr$47,709

Sell every share at vest; invest the after-tax cash at the market return for 1 yr, then liquidate. Diversified — no single-stock concentration risk.

Hold 1 yr

Vest value (shares × price)$80,000
Vest tax (federal + state + FICA)
Net at year 1 yr$42,728

Sold 444 shares to cover vest tax (net-settled); kept 556 shares 1 yr to qualify for long-term capital gains.

Social Security + Medicare are payroll taxes (collectively called FICA) — they apply because you're still employed at vest.

Both columns are stated in year-1 yr dollars. The sell side compounds at the market return; the hold side compounds at your single-stock expected return after a 20% volatility drag.

Estimates only. Assumes net-settled (sell-to-cover) vesting; double-trigger and pre-IPO RSUs are out of scope. Excludes multi-state moves, AMT interactions on other equity, and 83(b) elections. Not financial advice.

You evaluated one RSU vest. The beta plans every vest of every grant across years, with concentration and AMT in the loop.

Request beta access →

Related calculators: RSU Lot Order Calculator · Stock Concentration Calculator

About Insulet

Insulet (PODD) is a public Medical Device company, incorporated in Delaware and headquartered in Acton, MA.

Last close: $148.03 per share (as of 2026-08-18).

Equity grants at Insulet typically include restricted stock units (RSUs).

The company makes the Omnipod, an insulin pump worn as a small adhesive pod with no tubing, which is replaced every few days rather than serviced. The disposable design converts a durable-equipment purchase into recurring consumable revenue and lowers the barrier for patients who reject conventional pumps. Expansion into type 2 diabetes widens the addressable population well beyond the original market. Pharmacy rather than durable-medical-equipment distribution has simplified patient access. Headquarters are in Acton, Massachusetts.

Sources: sec.gov

OptionsAhoy is an independent tool and is not affiliated with, endorsed by, or sponsored by Insulet.

Insulet (PODD) RSUs vest as ordinary income at the price on vest day. The decision is whether to sell at vest and reinvest, or hold the shares through the 12-month LTCG cliff. This calculator runs both paths through the same after-tax math so you can compare like-for-like.

Example: 500 Insulet (PODD) RSUs vesting at $148.03 per share is $74,015 of ordinary income on vest day. After roughly 32% combined federal + state + FICA (~$23,685), the post-tax share value is ~$50,330. Holding 12 months for long-term capital-gains treatment then only matters for the price change between vest and sale; the ordinary income at vest is already locked in. The calculator runs both paths through the same after-tax math.

All Insulet tools → · Use the generic RSU Sell-vs-Hold Calculator for any company. Diversifying multiple RSU lots? See the lot-by-lot sell order →

Insulet equity questions

Should I sell or hold my Insulet RSUs at vest?
Insulet restricted stock units (RSUs) are taxed as ordinary income on their value at vest whether or not you sell. The only open decision is what to do with the shares afterward: sell at vest and reinvest, or hold past twelve months for long-term capital-gains treatment on any further gain. The calculator above runs both paths through the same after-tax math so you can compare them directly.
Does Insulet grant ISOs, NSOs, or RSUs?
Equity compensation at Insulet typically takes the form of restricted stock units (RSUs). Restricted stock units are taxed as ordinary income when they vest.
Find another companyMedical Devices peers

One piece of the puzzle.

OptionsAhoy plans your Insulet equity alongside hedging, vesting, and de-concentration, across bullish, neutral, and bearish market scenarios. Free during beta.

Request beta access